Navigation Links
Acuo Technologies Updates the Universal Clinical Platform
Date:2/21/2012

BLOOMINGTON, Minn., Feb. 21, 2012 /PRNewswire/ -- Acuo Technologies®, the leader in high-performance software and services for intelligent clinical content management and data migration, is pleased to announce the latest release of its award winning Universal Clinical Platform (UCP3).  Version 6.0 adds advanced features required for next generation Vendor Neutral Archive solutions with standards based clinical registry and repository capabilities, unmatched infrastructure versatility, and increased performance and scalability.

AcuoAccess™ and AcuoWorkflow™ are introduced with this release.  These components offer an intelligence layer based on Web Services and RESTful APIs that facilitate enterprise workflow, a comprehensive tag mapping platform with input, output and query support, and access to DICOM and non-DICOM data, including support for the MINT protocol.  "Acuo is pleased to offer next generation capabilities by exposing its enterprise VNA collaboration and orchestration capabilities through Web Services," stated Shannon Werb, Chief Operating Officer.  "This functionality will allow Acuo's customers and partners to experience unprecedented access, control and flexibility – resulting in true data ownership." 

UCP3 introduces enterprise Master Patient Index capabilities, based on the PIX and PDQ IHE actors along with a "plugin" architecture that provides a flexible extension to varying MPI requirements within complex customer and HIE environments.  The cloud enabled solution is further augmented by integrations to third party cloud storage providers such as Nirvanix® and Scality® (based on Amazon S3).

UCP3 version 6.0 enhances non-DICOM support through an innovative enterprise approach based on the IHE XDS.b profile, including and XDS.b Repository and Registry, enabling management of any non-DICOM content in a standard based context.  "Data can be stored and retrieved via the IHE Web Service based transactions or RESTful APIs," stated Razvan Atanasiu, Chief Technical Officer, "this facilitates scalability via streaming and also simplifies the workflow for customers who do not have an IHE infrastructure already deployed.  Acuo has successfully completed the testing of these actors at the 2012 IHE Connectathon and is also proud to announce its participation in the HIMSS IHE Interoperability Showcase."

About Acuo Technologies

Acuo Technologies, with headquarters in Minneapolis, MN, was founded in 2000 with the objective of developing the first enterprise-wide collaborative Universal Clinical Platform (UCP3) solution for medical image content, both DICOM and Non-DICOM. Today, Acuo supports implementations of UCP3 around the world, including locations in Africa, Australia, Canada, New Zealand, South America, United States and the United Kingdom.  For more information on providing superior medical image lifecycle and content management while simplifying operations and reducing costs, visit www.acuotech.com.

DICOM is the registered trademark of the National Electrical Manufacturers Association for its standards publications relating to digital communications of medical information.

 


'/>"/>
SOURCE Acuo Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
3. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
4. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
5. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
8. Senesco Technologies Initiates Preclinical Studies for Cancer Target
9. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
10. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
11. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ORANGE COUNTY, Calif. , Oct. 10, 2017  NDS received ... Mobile  — a medical-grade battery-powered display stand specifically designed for ... aims to transform technology into a clinical solution to support the ... costs. Innovative Design ... NDS ZeroWire Mobile Wireless Solution ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
Breaking Medicine News(10 mins):